Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and Management

被引：0
|
作者：
Sood, Siddhartha [1 ]
Bagit, Ahmed [1 ]
Waked, Jihad Abou Ali [2 ]
Perlmutter, Jonah [1 ]
Tarafdar, Nawar [2 ]
Maliyar, Khalad [3 ]
Sachdeva, Muskaan [3 ]
Abduelmula, Abrahim [3 ]
Mufti, Asfandyar [3 ,4 ]
Yeung, Jensen [3 ,4 ,5 ,6 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Western Ontario, Fac Med, London, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[5] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
[6] Prob Med Res, Waterloo, ON, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2025年
关键词：
severe cutaneous adverse reaction; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms; acute generalized exanthematous pustulosis; immune checkpoint inhibitor; systematic review;
D O I：
10.1177/12034754251320632
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors A Systematic Review
    Nadelmann, Emily R.
    Yeh, Jennifer E.
    Chen, Steven T.
    JAMA ONCOLOGY, 2022, 8 (01) : 130 - 138
  • [2] Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
    Chen, Chieh-Hsun
    Yu, Hsin-Su
    Yu, Sebastian
    CURRENT ONCOLOGY, 2022, 29 (04) : 2871 - 2886
  • [3] Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System
    Godfrey, Hannah
    Jedlowski, Patrick
    Thiede, Rebecca
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (03) : 243 - 253
  • [4] Cutaneous adverse events caused by immune checkpoint inhibitors
    Quach, Henry T.
    Johnson, Douglas B.
    LeBoeuf, Nicole R.
    Zwerner, Jeffrey P.
    Dewan, Anna K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 956 - 966
  • [5] Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
    Gao, Ling
    Yang, Xi
    Yi, Cheng
    Zhu, Hong
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [6] Unique Clinical Characteristics and Prognosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions
    Park, Hye Jung
    Yun, James
    Kang, Dong Yoon
    Park, Jung-Won
    Koh, Young-Il
    Kim, Sujeong
    Kim, Sae Hoon
    Nam, Young Hee
    Jeong, Yi Yeong
    Kim, Cheol-Woo
    Park, Hye-Kyung
    Kim, Sang Hyon
    Kang, Hye-Ryun
    Jung, Jae-Woo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (08): : 2739 - +
  • [7] Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
    Muntyanu, Anastasiya
    Netchiporouk, Elena
    Gerstein, William
    Gniadecki, Robert
    Litvinov, Ivan V.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (01) : 59 - 76
  • [8] Potentially life-threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors
    Coleman, Emily
    Olamiju, Brianna
    Leventhal, Jonathan
    ONCOLOGY REPORTS, 2021, 45 (03) : 891 - 898
  • [9] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [10] Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review
    Zhou, Jia
    Wang, Chuan-Peng
    Li, Jun
    Zhang, Han-Lin
    He, Chun-Xia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345